TERT and JAK2 polymorphisms define genetic predisposition to myeloproliferative neoplasms in Japanese patients.

Matsuguma, Masafumi; Yujiri, Toshiaki; Yamamoto, Kaoru; Kajimura, Yasuko; Tokunaga, Yoshihiro; Tanaka, Mayumi; Tanaka, Yoshinori; Nakamura, Yukinori; Tanizawa, Yukio

Matsuguma, Masafumi; Yujiri, Toshiaki; Yamamoto, Kaoru; Kajimura, Yasuko; Tokunaga, Yoshihiro; Tanaka, Mayumi; Tanaka, Yoshinori; Nakamura, Yukinori; Tanizawa, Yukio.

Afiliación

Matsuguma M; Division of Endocrinology, Metabolism, Hematological Sciences and Therapeutics, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan.
Yujiri T; Division of Clinical Laboratory Sciences, Yamaguchi University Graduate School of Medicine, 1-1-1 Minamikogushi, Ube, 755-8505, Yamaguchi, Japan. yujirit@yamaguchi-u.ac.jp.
Yamamoto K; Division of Endocrinology, Metabolism, Hematological Sciences and Therapeutics, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan.
Kajimura Y; Division of Endocrinology, Metabolism, Hematological Sciences and Therapeutics, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan.
Tokunaga Y; Division of Endocrinology, Metabolism, Hematological Sciences and Therapeutics, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan.
Tanaka M; Division of Endocrinology, Metabolism, Hematological Sciences and Therapeutics, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan.
Tanaka Y; Division of Endocrinology, Metabolism, Hematological Sciences and Therapeutics, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan.
Nakamura Y; Division of Endocrinology, Metabolism, Hematological Sciences and Therapeutics, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan.
Tanizawa Y; Division of Endocrinology, Metabolism, Hematological Sciences and Therapeutics, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan.

Int J Hematol ; 110(6): 690-698, 2019 Dec.

Article en En | MEDLINE | ID: mdl-31571131

Asunto(s)

Predisposición Genética a la Enfermedad; Janus Quinasa 2/genética; Trastornos Mieloproliferativos/genética; Polimorfismo Genético; Telomerasa/genética; Anciano; Estudios de Casos y Controles; Femenino; Haplotipos; Humanos; Japón/epidemiología; Masculino; Persona de Mediana Edad; Policitemia Vera/genética; Mielofibrosis Primaria/genética; Trombocitemia Esencial/genética

Palabras clave

Digital PCR; JAK2; Myeloproliferative neoplasms; Single nucleotide polymorphisms; TERT

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Polimorfismo Genético / Telomerasa / Predisposición Genética a la Enfermedad / Janus Quinasa 2 / Trastornos Mieloproliferativos Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Int J Hematol Asunto de la revista: HEMATOLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Japón

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google